Preliminary injunctions are strong medicine in patent infringement cases. But the U.S. Court of Appeals for the Federal Circuit seemed ready to uphold one Thursday in a San Francisco case involving gene sequencing technology.
Federal Circuit Judges Kathleen O’Malley and Evan Wallach sounded convinced that U.S. District Judge William Alsup of the Northern District of California didn’t err when he blocked Qiagen N.V. last summer from selling its GeneReader machines in the United States.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
